Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : INCR -- Incara Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (89)	4/20/2001 2:16:39 PM
From: keokalani'nui	Read Replies (1) \| Respond to of 196

Friday April 20, 8:55 am Eastern Time Press Release SOURCE: Incara Pharmaceuticals Corporation Eugene J. McDonald Joins Board of Incara Pharmaceuticals RESEARCH TRIANGLE PARK, N.C., April 20 /PRNewswire/ -- Incara Pharmaceuticals Corporation (Nasdaq: INCR - news) announced today that Eugene J. McDonald, Executive Vice President, Office of Investment Counsel at Duke University, has been elected to the company's Board of Directors. Mr. McDonald founded and was the first president and CEO of Duke Management Company, the investment management affiliate of Duke University. Mr. McDonald has served at Duke University for more than two decades. In addition to his current position and his role in founding Duke Management Company, Mr. McDonald was Duke's Chief Financial/Administrative Officer from 1984 to 1990, and, prior to this, served as Vice President and University Counsel. He began his career as professor of law at Georgetown Law School, and as an attorney in the corporate/business practice of Brobeck, Phleger and Harrison in San Francisco. Mr. McDonald is the lead director of the Deutsche Bank/Alex Brown Fund Family, and also serves on the boards of directors of Red Hat, Inc. and National Commerce Bank Corporation. He has also served on a number of advisory boards, including those of the New York Stock Exchange's PMAC Committee and T. Rowe Price Strategic Partners. Mr. McDonald received his undergraduate and law degrees from the University of San Francisco. ``I have known the management of Incara, both professionally and personally, for over ten years,'' Mr. McDonald stated. ``In that time they have shown an ability to identify and develop innovative technologies in the biotechnology field. This is an exciting time for Incara, as it has interesting technologies that could become important therapies. I'm pleased to become a part of the team.'' ``Gene McDonald has outstanding credentials, including his experience overseeing the investments of one of the largest university endowments in the country,'' commented Clayton I. Duncan, President and CEO of Incara. ``His expertise in the investment and capital markets will be valuable for Incara, and we are delighted to have him join our Board of Directors.''